16 min listen
Managing and treating toxicities associated with CAR-T therapy: CRS, ICANS & infections
FromVJHemOnc Podcast
Managing and treating toxicities associated with CAR-T therapy: CRS, ICANS & infections
FromVJHemOnc Podcast
ratings:
Length:
14 minutes
Released:
Mar 16, 2023
Format:
Podcast episode
Description
CAR-T cell therapy represents a major breakthrough in the treatment of hematological malignancies, including multiple myeloma, non-Hodgkin lymphoma (NHL), and...
The post Managing and treating toxicities associated with CAR-T therapy: CRS, ICANS & infections appeared first on VJHemOnc.
The post Managing and treating toxicities associated with CAR-T therapy: CRS, ICANS & infections appeared first on VJHemOnc.
Released:
Mar 16, 2023
Format:
Podcast episode
Titles in the series (100)
CAR T-cells in myeloma: exploratory targets, payment models & treatment sequence: CAR T-cell therapy presents the opportunity to completely revolutionize the treatment of multiple myeloma, with research currently exploring the optimal... by VJHemOnc Podcast